Ultime notizie per Bavarian Nordic (OTC:BVNKF) Azioni

Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

BAVARIAN NORDIC A S by Bavarian Nordic A/S

Bavarian Nordic AS

First mpox case linked to African outbreak reported in U.K.

Bavarian Nordic reports results for first nine months; reaffirms upgraded guidance for FY24

Bavarian Nordic A/S 2024 Q3 - Results - Earnings Call Presentation

Bavarian Nordic A/S (BVNKF) Q3 2024 Earnings Call Transcript

Vaccine stocks drop on concerns about RFK Jr. heading HHS

Vaccine stocks drop on concerns about RFK Jr. heading HHS (update)

First mpox case linked to African outbreak reported in U.S.

Bavarian Nordic's Mpox Moment Fades, But Diversification Shines

Bullish On Bavarian Nordic's Vaccine Portfolio And Revenue Potential In 2025

WHO extends mpox emergency; Canada reports first Clade I case

APDN

BNTX

BVNKF

BVNRY

CMRX

CODX

GOVX

MRNA

NVAX

RHHBF

RHHBY

SIGA

TNXP

Screenshot 2024-09-18 at 12.30.33 AM

Biotech

General

New Hope For Mpox? How TNX-801 Could Meet The WHO&#39;s Vaccine Targets For A Safer, Single-Dose Solution

Bavarian Nordic

Comments

Bavarian Nordic

Notizie

Ultime notizie per Bavarian Nordic (OTC:BVNKF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO